HuagongsheHuagongshe Chemistry Print Report · For research reference only
(2S)-1-tert-butoxycarbonyl-2(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)ethyl)-piperidine → 1-(N-cyclooctyl-gamma-tert-butyl-L-glutamyl)-2-(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)-ethyl)-piperidine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (2S)-1-tert-butoxycarbonyl-2(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)ethyl)-piperidine | HCID 20794986 | — |
| Reactant | N-cyclooctyl-gamma-tert-butyl-L-glutamic acid | HCID 20794995 | — |
| Product | 1-(N-cyclooctyl-gamma-tert-butyl-L-glutamyl)-2-(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)-ethyl)-piperidine | HCID 20794977 | 58% |
Reaction Steps
N-Cyclooctyl-γ-tert-butyl-L-glutamic acid (8a, 344 mg, 1.1 mmol) and 2-(2-(1-allyloxycarbonylamino-isoquinolin-6-oxy)-ethyl)-piperidine (1g, 391 mg, 1.1 mmol) were coupled, using the methodology described in Example 1i, providing 380 mg (58%) of the title compound as a colourless oil. ESI-MS: 651.3 (M+H)+. Rf (silica gel; dichloromethane/methanol, 9:1, v/v): 0.23.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06903107B1 |
| Source dataset | uspto-grants-2005_06 |
| ORD ID | ord-eb3c6f24aac54ee98e6130be4c9011d4 |
| Source note | uspto-grants-2005_06 |